SUBSCRIBE
SUBSCRIBE
News   Business

Ariad Pharmaceuticals, Inc. to Receive $2.5 Million from Partner Merck & Co., Inc.

August 6, 2008 | 
1 min read
CAMBRIDGE, Mass. (AP) -- Ariad Pharmaceuticals Inc. said Wednesday it will receive a $2.5 million payment from partner Merck & Co. for moving a cancer drug into midstage clinical trials.
Alliances
Merck & Co.
MORE ON THIS TOPIC
New Opportunity, Businessman Walks Up Stairs Finds Exit Big Door
C-suite
Sarepta CEO Doug Ingram To Step Down as Muscular Dystrophy Mission Hits Home
February 25, 2026
 · 
2 min read
 · 
Annalee Armstrong
A pill bottle in between two injector pens
Weight loss
Novo Leans Into Oral Route With Weight Loss Partnership Worth up to $2.1B
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac
Dollar boat swimming on paper waves
Startups
Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac
Art collage, coins, and arrow up on the red and paper background. Concept of business and financial growth.
Funding
Slate, Alveus Raise Hefty Series A Hauls for Migraine, Obesity Drugs
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac